Pharmosa Biopharm (ROCO:6875) Change In Inventory : NT$4.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Pharmosa Biopharm Change In Inventory?

Pharmosa Biopharm's change in inventory for the quarter that ended in Mar. 2025 was NT$-10.1 Mil. It means Pharmosa Biopharm's inventory increased by NT$10.1 Mil from Dec. 2024 to Mar. 2025 .

Pharmosa Biopharm's change in inventory for the fiscal year that ended in Dec. 2024 was NT$-2.8 Mil. It means Pharmosa Biopharm's inventory increased by NT$2.8 Mil from Dec. 2023 to Dec. 2024 .

Pharmosa Biopharm's Total Inventories for the quarter that ended in Mar. 2025 was NT$34.9 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Pharmosa Biopharm's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pharmosa Biopharm Change In Inventory Historical Data

The historical data trend for Pharmosa Biopharm's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmosa Biopharm Change In Inventory Chart

Pharmosa Biopharm Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-21.91

-2.83

Pharmosa Biopharm Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial												-16.96	2.83	17.09	-5.79	-10.15

Pharmosa Biopharm Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$4.0 Mil.

Pharmosa Biopharm (ROCO:6875) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pharmosa Biopharm's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	29.814	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Pharmosa Biopharm's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	29.814
	=	0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pharmosa Biopharm's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	29.814	/	0
	=	N/A

Pharmosa Biopharm Change In Inventory Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmosa Biopharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.66, Sanchong Road, 3rd Floor-3, Nangang District, Taipei, TWN, 11502

Website

https://www.pharmosa.com.tw

Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology.

Pharmosa Biopharm Headlines

No Headlines